A detailed history of High Falls Advisors, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, High Falls Advisors, Inc holds 3,872 shares of MRK stock, worth $389,561. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,872
Previous 4,057 4.56%
Holding current value
$389,561
Previous $502,000 12.55%
% of portfolio
0.1%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$111.15 - $128.97 $20,562 - $23,859
-185 Reduced 4.56%
3,872 $439,000
Q2 2024

Aug 15, 2024

BUY
$123.8 - $132.96 $5,571 - $5,983
45 Added 1.12%
4,057 $502,000
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $20,383 - $23,750
180 Added 4.7%
4,012 $529,000
Q4 2023

Feb 15, 2024

SELL
$100.18 - $109.02 $2,304 - $2,507
-23 Reduced 0.6%
3,832 $417,000
Q3 2023

Nov 15, 2023

BUY
$102.95 - $114.33 $411 - $457
4 Added 0.1%
3,855 $396,000
Q2 2023

Aug 15, 2023

BUY
$108.61 - $118.38 $543 - $591
5 Added 0.13%
3,851 $444,000
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $10,705 - $11,945
104 Added 2.78%
3,846 $409,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $30,866 - $39,574
353 Added 10.42%
3,742 $415,000
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $5,832 - $6,552
-69 Reduced 2.0%
3,389 $292,000
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $11,438 - $12,965
-137 Reduced 3.81%
3,458 $315,000
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $8,674 - $9,723
-118 Reduced 3.18%
3,595 $295,000
Q4 2021

Feb 15, 2022

BUY
$72.28 - $90.54 $216 - $271
3 Added 0.08%
3,713 $285,000
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $13,475 - $14,820
188 Added 5.34%
3,710 $279,000
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $7,593 - $8,399
108 Added 3.16%
3,522 $274,000
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $5,026 - $5,921
-73 Reduced 2.09%
3,414 $263,000
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $250,261 - $277,739
3,487 New
3,487 $272,000
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $254,300 - $288,251
-3,475 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $9,647 - $10,977
137 Added 4.1%
3,475 $269,000
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $443 - $614
7 Added 0.21%
3,338 $257,000
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $7,447 - $8,403
96 Added 2.97%
3,331 $303,000
Q3 2019

Nov 21, 2019

SELL
$76.08 - $82.93 $76,003 - $82,847
-999 Reduced 23.59%
3,235 $272,000
Q2 2019

Aug 15, 2019

BUY
$69.84 - $81.59 $628 - $734
9 Added 0.21%
4,234 $355,000
Q1 2019

May 16, 2019

BUY
$69.58 - $79.36 $36,320 - $41,425
522 Added 14.1%
4,225 $351,000
Q4 2018

Feb 15, 2019

BUY
$65.24 - $75.71 $65 - $75
1 Added 0.03%
3,703 $283,000
Q3 2018

Nov 16, 2018

SELL
$57.69 - $67.84 $115,264 - $135,544
-1,998 Reduced 35.05%
3,702 $263,000
Q2 2018

Aug 15, 2018

BUY
$50.83 - $59.72 $289,731 - $340,404
5,700 New
5,700 $346,000
Q4 2017

Feb 16, 2018

SELL
$51.62 - $61.64 $161,260 - $192,563
-3,124 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$58.67 - $63.13 $183,285 - $197,218
3,124
3,124 $200,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $255B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track High Falls Advisors, Inc Portfolio

Follow High Falls Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Falls Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on High Falls Advisors, Inc with notifications on news.